AngioJet® (MEDRAD ... and simultaneously evacuates the thrombotic material from the vessel Rescue™ (Boston Scientific, MA, USA) 4.5 F aspiration catheter advanced over a guidewire through ...

She had been treated 8 years prior for a right popliteal artery occlusion via overnight CDT with Ekos infusion catheter (Boston Scientific Corporation) followed by rheolytic thrombectomy with AngioJet ...

Stifel raised the firm’s price target on Boston Scientific (BSX) to $120 from $115 and keeps a Buy rating on the shares after having hosted ...

Boston Scientific (NYSE:BSX – Get Free Report) had its price objective lifted by equities research analysts at Raymond James ...

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Barclays raised the firm’s price target on Boston Scientific (BSX) to $118 from $111 and keeps an Overweight rating on the shares. The firm ...

In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...

Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that develops, manufactures, and markets a broad range of innovative products.

CEO Michael Mahoney highlighted the company’s exceptional performance in 2024, with operational sales growth of 23% in Q4 and 18.5% for the full year. Organic sales grew 20% in Q4, exceeding guidance.

Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...

But that could be changing soon. Martha Sheridan, head of the Meet Boston tourism bureau, just returned from a trade mission to Hyderabad, organized by the Brand USA marketing partnership ...